Last reviewed · How we verify
The Effect of Rifapentine on Plasma Concentrations of Raltegravir
The aim of this study is to study the effect of rifapentine on plasma concentrations of raltegravir.
Details
| Lead sponsor | The University of Texas Health Science Center at San Antonio |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 27 |
| Start date | 2009-02 |
| Completion | 2011-08 |
Conditions
- Healthy
Interventions
- Raltegravir and rifapentine
Primary outcomes
- Raltegravir pharmacokinetics (Cmin and AUC) — Eight weeks
Countries
United States